62
Participants
Start Date
October 12, 2019
Primary Completion Date
December 15, 2024
Study Completion Date
May 15, 2025
Rifapentine
Rifapentine. Initial dose will be 25mg/kg. Based on interim analysis, this may be adjusted throughout the study to achieve target exposures. The standalone water-dispersible rifapentine tablet may be used to adjust the rifapentine doses, if needed.
Isoniazid
Isoniazid. 25mg/kg
Desmond Tutu TB Center, University of Stellenbosch, Stellenbosch
Collaborators (1)
University of Stellenbosch
OTHER
Johns Hopkins University
OTHER
Sanofi
INDUSTRY
University of Cape Town
OTHER
Chris Hani Baragwanath Academic Hospital
OTHER
Washington D.C. Veterans Affairs Medical Center
FED
Centers for Disease Control and Prevention
FED